Literature DB >> 528265

Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo.

P R Twentyman.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 528265     DOI: 10.1016/0360-3016(79)90641-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

1.  Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro.

Authors:  P J Hepburn; J R Masters
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Experimental chemotherapy studies: intercomparison of assays.

Authors:  P R Twentyman
Journal:  Br J Cancer Suppl       Date:  1980-04

Review 4.  Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity.

Authors:  G W Barendsen
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Responses of a murine B16 melanoma to pharmacotherapy studied and compared with different assay systems.

Authors:  Y Kuwashima; O Matsubara; T Kasuga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

7.  Resistance to vincristine of human cells grown as multicellular spheroids.

Authors:  E Wibe
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

8.  Advantage of reduced oxygen tension in growth of human melanomas in semi-solid cultures: quantitative analysis.

Authors:  R M Joyce; P C Vincent
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

9.  Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.

Authors:  M P Law; D G Hirst; J M Brown
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

10.  The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.

Authors:  R R Weichselbaum; J B Little
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.